Human TSC2 Mutant Cells Exhibit Aberrations in Early Neurodevelopment Accompanied by Changes in the DNA Methylome

Mary-Bronwen L Chalkley,Lindsey N Guerin,Tenhir Iyer,Samantha Mallahan,Sydney N Nelson,Mustafa Sahin,Emily Hodges,Kevin C Ess,Rebecca A Ihrie

DOI: https://doi.org/10.1101/2024.06.04.597443

2024-06-06

Abstract:Tuberous Sclerosis Complex (TSC) is a debilitating developmental disorder characterized by a variety of clinical manifestations. While benign tumors in the heart, lungs, kidney, and brain are all hallmarks of the disease, the most severe symptoms of TSC are often neurological, including seizures, autism, psychiatric disorders, and intellectual disabilities. TSC is caused by loss of function mutations in the TSC1 or TSC2 genes and consequent dysregulation of signaling via mechanistic Target of Rapamycin Complex 1 (mTORC1). While TSC neurological phenotypes are well-documented, it is not yet known how early in neural development TSC1/2-mutant cells diverge from the typical developmental trajectory. Another outstanding question is the contribution of homozygous-mutant cells to disease phenotypes and whether such phenotypes are also seen in the heterozygous-mutant populations that comprise the vast majority of cells in patients. Using TSC patient-derived isogenic induced pluripotent stem cells (iPSCs) with defined genetic changes, we observed aberrant early neurodevelopment in vitro, including misexpression of key proteins associated with lineage commitment and premature electrical activity. These alterations in differentiation were coincident with hundreds of differentially methylated DNA regions, including loci associated with key genes in neurodevelopment. Collectively, these data suggest that mutation or loss of TSC2 affects gene regulation and expression at earlier timepoints than previously appreciated, with implications for whether and how prenatal treatment should be pursued.

Developmental Biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how loss - of - function mutations in the TSC2 gene affect early neural development, especially the early cortical development stage modeled in human induced pluripotent stem cells (iPSCs). The study focused on the abnormal manifestations of TSC2 - mutant cells in early neural development, including changes in cell fate determination, premature expression of neuronal markers, and an abnormal increase in neural activity. In addition, the study also explored whether these phenotypic changes are related to global changes in DNA methylation, especially how the DNA methylation pattern in TSC2 - mutant cells differs from that in normal cells, thereby affecting gene expression and cell differentiation.

Specifically, the paper observed the phenotypic differences of these cells in 3D organoid cultures or 2D monolayer cultures by using iPSCs with different mutation states of the TSC2 gene (wild - type, heterozygous mutation, homozygous mutation) and their derived neural precursor cells (NPCs). The study found that TSC2 - mutant cells showed phenomena such as decreased expression of neural precursor cell markers, premature expression of neuronal markers, and an abnormal increase in neural activity, and these changes were accompanied by significant changes in the DNA methylation pattern. These results suggest that the loss of function of the TSC2 gene not only affects cell fate determination but may also affect gene expression by changing the DNA methylation state, thereby affecting the process of early neural development.

In summary, this study aims to reveal the specific influence mechanism of TSC2 mutations on early neural development, especially to explore these effects from the perspective of epigenetics, providing a theoretical basis for understanding the pathogenesis of TSC and developing early intervention strategies.